Ensign Peak Advisors, Inc Biotechnology

Ensign Peak Advisors, Inc

$51.2 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ADMA Adma Biologics, Inc.	$3.04B	$1.3 Million 0.0% of portfolio	65,550	Q4 2024 New
CYTK Cytokinetics Inc	$5.61B	$1.28 Million 0.0% of portfolio	31,796	Q1 2025 Reduced 89.29%
ROIV Roivant Sciences Ltd.	$14B	$1.19 Million 0.0% of portfolio	118,378	Q1 2024 Reduced 86.07%
KRYS Krystal Biotech, Inc.	$5.22B	$1.18 Million 0.0% of portfolio	6,569	Q2 2024 Reduced 68.59%
CPRX Catalyst Pharmaceuticals, Inc.	$2.19B	$1.17 Million 0.0% of portfolio	48,160	Q1 2024 Reduced 4.8%
ACAD Acadia Pharmaceuticals Inc	$3.54B	$1 Million 0.0% of portfolio	60,450	Q1 2024 Reduced 4.8%
VCYT Veracyte, Inc.	$2.59B	$972,000 0.0% of portfolio	32,815	Q1 2024 Reduced 4.8%
CRSP Crispr Therapeutics Ag	$4.4B	$968,000 0.0% of portfolio	28,464	Q1 2024 Reduced 4.8%
AGIO Agios Pharmaceuticals, Inc.	$2.19B	$935,000 0.0% of portfolio	31,920	Q1 2024 Reduced 4.8%
RYTM Rhythm Pharmaceuticals, Inc.	$5.85B	$935,000 0.0% of portfolio	17,659	Q1 2024 Reduced 4.8%
XENE Xenon Pharmaceuticals Inc.	$2.43B	$875,000 0.0% of portfolio	26,094	Q4 2024 Reduced 84.0%
SWTX Spring Works Therapeutics, Inc.	$2.93B	$849,000 0.0% of portfolio	19,241	Q1 2025 Added 1.05%
FOLD Amicus Therapeutics, Inc.	$2.52B	$806,000 0.0% of portfolio	98,806	Q1 2024 Reduced 4.8%
IMVT Immunovant, Inc.	$3.55B	$781,000 0.0% of portfolio	28,406	Q1 2025 Added 44.15%
BCRX Biocryst Pharmaceuticals Inc	$1.26B	$663,000 0.0% of portfolio	88,400	Q1 2024 Reduced 4.8%
APLS Apellis Pharmaceuticals, Inc.	$2.25B	$642,000 0.0% of portfolio	29,397	Q1 2025 Reduced 62.83%
ARWR Arrowhead Pharmaceuticals, Inc.	$4.01B	$618,000 0.0% of portfolio	48,541	Q1 2024 Reduced 4.8%
BEAM Beam Therapeutics Inc.	$1.6B	$568,000 0.0% of portfolio	29,111	Q1 2024 Reduced 4.8%
XFOR X4 Pharmaceuticals, Inc	$273M	$536,000 0.0% of portfolio	2,235,655	Q1 2025 Reduced 12.21%
AUPH Aurinia Pharmaceuticals Inc.	$2.02B	$512,000 0.0% of portfolio	63,735	Q1 2024 Reduced 4.8%
HRMY Harmony Biosciences Holdings, Inc.	$1.82B	$444,000 0.0% of portfolio	13,385	Q1 2024 Reduced 4.8%
CLDX Celldex Therapeutics, Inc.	$1.12B	$437,000 0.0% of portfolio	24,078	Q1 2025 Added 2.77%
VIR Vir Biotechnology, Inc.	$696M	$413,000 0.0% of portfolio	63,874	Q3 2024 Added 27.05%
ARDX Ardelyx, Inc.	$878M	$406,000 0.0% of portfolio	82,800	Q1 2025 Added 11.97%
XNCR Xencor Inc	$818M	$388,000 0.0% of portfolio	36,527	Q1 2024 Reduced 4.8%
MLTX Moon Lake Immunotherapeutics	$374M	$357,000 0.0% of portfolio	9,139	Q4 2024 Reduced 78.4%
NVAX Novavax Inc	$587M	$335,000 0.0% of portfolio	52,400	Q4 2024 Added 16.7%
VERA Vera Therapeutics, Inc.	$681M	$325,000 0.0% of portfolio	13,550	Q4 2024 Added 15.32%
LEGN Legend Biotech Corp	$5.37B	$307,000 0.0% of portfolio	9,050	Q1 2025 Added 15.29%
MRUS Merus N.V.	$4.36B	$282,000 0.0% of portfolio	6,700	Q1 2025 Reduced 94.12%
NTLA Intellia Therapeutics, Inc.	$927M	$278,000 0.0% of portfolio	39,169	Q4 2024 Added 2.89%
PRTA Prothena Corp Public LTD CO	$481M	$267,000 0.0% of portfolio	21,643	Q2 2024 Added 30.43%
IOVA Iovance Biotherapeutics, Inc.	$287M	$264,000 0.0% of portfolio	79,442	Q1 2025 Reduced 86.24%
ARVN Arvinas, Inc.	$508M	$259,000 0.0% of portfolio	36,970	Q1 2025 Added 24.19%
DYN Dyne Therapeutics, Inc.	$1.2B	$210,000 0.0% of portfolio	20,150	Q1 2025 Reduced 93.62%
RLAY Relay Therapeutics, Inc.	$825M	$170,000 0.0% of portfolio	64,900	Q4 2024 Added 17.04%
COGT Cogent Biosciences, Inc.	$1.03B	$112,000 0.0% of portfolio	18,825	Q1 2025 New
ABUS Arbutus Biopharma Corp	$682M	$76,000 0.0% of portfolio	21,850	Q1 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.